Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNET
2426
VNET Group
VNET
$2.21B
| $3.77M | ﹤0.01% |
445,474
-198,000
| -31% | -$1.83M |
|
2427
PUT
Urban Outfitters
URBN
$6.61B
| $3.76M | ﹤0.01% |
50,000
| – | – |
|
|
ECO
2428
Okeanis Eco Tankers
ECO
$2.33B
| $3.76M | ﹤0.01% |
111,143
+102,643
| +1,208% | +$3.48M |
|
|
VRE
2429
DELISTED
Veris Residential
VRE
| $3.76M | ﹤0.01% |
252,699
-68,093
| -21% | -$1.01M |
|
2430
Brighthouse Financial
BHF
$3.39B
| $3.76M | ﹤0.01% |
58,016
-92,503
| -61% | -$5.44M |
|
2431
Rapid7
RPD
$887M
| $3.76M | ﹤0.01% |
247,135
-66,202
| -21% | -$1.09M |
|
2432
Itaú Unibanco
ITUB
$80.3B
| $3.76M | ﹤0.01% |
524,552
+453,441
| +638% | +$3.23M |
|
2433
PUT
Mobileye
MBLY
$7.59B
| $3.76M | ﹤0.01% |
359,700
+329,700
| +1,099% | +$4.12M |
|
2434
Bank of Montreal
BMO
$129B
| $3.74M | ﹤0.01% |
28,846
+449
| +2% | +$56.9K |
|
2435
CALL
Trupanion
TRUP
$1.35B
| $3.74M | ﹤0.01% |
100,000
| – | – |
|
2436
First Bancorp
FBNC
$2.75B
| $3.73M | ﹤0.01% |
73,512
+13,900
| +23% | +$705K |
|
2437
NBT Bancorp
NBTB
$2.8B
| $3.72M | ﹤0.01% |
89,559
+14,655
| +20% | +$609K |
|
|
DCH
2438
Dauch Corp
DCH
$1.61B
| $3.72M | ﹤0.01% |
579,673
+14,928
| +3% | +$92.8K |
|
2439
Amprius Technologies
AMPX
$1.9B
| $3.71M | ﹤0.01% |
469,906
+336,572
| +252% | +$3.85M |
|
2440
UL Solutions
ULS
$15.6B
| $3.71M | ﹤0.01% |
47,007
+43,417
| +1,209% | +$3.49M |
|
2441
PVH
PVH
$3.76B
| $3.7M | ﹤0.01% |
55,249
-1,141,760
| -95% | -$89.3M |
|
2442
Simply Good Foods
SMPL
$994M
| $3.7M | ﹤0.01% |
184,146
-261,705
| -59% | -$5.45M |
|
2443
ProShares S&P 500 ex-Financials ETF
SPXN
$80.9M
| $3.7M | ﹤0.01% |
50,000
-90,000
| -64% | -$6.61M |
|
2444
PUT
Iris Energy
IREN
$16B
| $3.69M | ﹤0.01% |
97,600
-276,000
| -74% | -$14.2M |
|
2445
AtriCure
ATRC
$2.2B
| $3.66M | ﹤0.01% |
92,606
+7,128
| +8% | +$261K |
|
2446
PUT
Hertz
HTZ
$848M
| $3.66M | ﹤0.01% |
711,700
| – | – |
|
2447
CALL
Insmed
INSM
$26.9B
| $3.65M | ﹤0.01% |
21,000
| – | – |
|
|
2448
PUT
Insmed
INSM
$26.9B
| $3.65M | ﹤0.01% |
21,000
| – | – |
|
2449
O-I Glass
OI
$1.05B
| $3.64M | ﹤0.01% |
246,766
+755
| +0.3% | +$9.99K |
|
2450
Vail Resorts
MTN
$5.23B
| $3.64M | ﹤0.01% |
27,377
-23,702
| -46% | -$3.49M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.